Income Statement for Xtl Biopharmaceutical (XTLB)

Watch the video to learn about the probability of Xtl Biopharmaceutical (XTLB) Chart Signal as of Apr 24 2014

Hotstocked Precision will calculate the probabilities of Xtl Biopharmaceutical (XTLB)

Rating:
Size: 656KB
Version: 1.1
Platform: Win/Mac
Downloads:
FREE DOWNLOAD
Income Statement for Xtl Biopharmaceutical
Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Profit
Total Revenue 2,369,000 938,000 -
Cost of Revenue 741,000 380,000 -
Gross Profit 1,628,000 558,000 -
Operating Expenses
Research Development 113,000 99,000 158,000
Selling General and Administrative 2,680,000 2,815,000 1,066,000
Non Recurring 1,729,000 - -
Others - - -
Total Operating Expenses - - -
Operating Income or Loss -2,894,000 -2,356,000 -1,224,000
Income from Continuing Operations
Total Other Income/Expenses Net 61,000 60,000 24,000
Earnings Before Interest And Taxes -2,833,000 -2,296,000 -1,200,000
Interest Expense 35,000 15,000 7,000
Income Before Tax -2,868,000 -2,311,000 -1,207,000
Income Tax Expense - - -
Minority Interest - - -
Net Income From Continuing Ops -3,713,000 -1,742,000 -1,207,000
Non-recurring Events
Discontinued Operations - - -
Extraordinary Items - - -
Effect Of Accounting Changes - - -
Other Items - - -
Net Income
Net Income -3,713,000 -1,742,000 -1,207,000
Preferred Stock And Other Adjustments - - -
Net Income Applicable To Common Shares -3,713,000 -1,742,000 -1,207,000
Get Adobe Flash player